Beyond Rescheduling: Inside NCIA’s 14th Annual National Cannabis Industry Lobby Days
Congress still has work to do
Momentum matters. So does showing up.
From May 12–14, 2026, cannabis business owners, operators, and advocates from across the country gathered in Washington, D.C. for the National Cannabis Industry Association’s 14th Annual National Cannabis Industry Lobby Days. Over a day and a half, NCIA members brought the realities of running a state-legal cannabis business directly to Congress at one of the most consequential moments for cannabis policy in decades.
The message was clear: historic progress has been made, but the work is far from finished.
This year’s Lobby Days came just weeks after the U.S. Department of Justice’s April final order rescheduling state-regulated medical cannabis to Schedule III of the Controlled Substances Act. For many in the industry, it marked a long-overdue acknowledgment of medical cannabis and the legitimacy of state programs. But as conversations on Capitol Hill quickly revealed, rescheduling also created new questions, uncertainty, and urgency.
Congress still has work to do.
To Read The Rest Of This Article On NCIA, Click Here
